Relmada Therapeutics, Inc. (RLMD)
NASDAQ: RLMD · Real-Time Price · USD
3.200
-0.040 (-1.23%)
At close: Oct 15, 2026, 4:00 PM EDT
3.210
+0.010 (0.31%)
After-hours: Oct 15, 2026, 7:30 PM EDT
Relmada Therapeutics Employees
Relmada Therapeutics had 17 employees as of December 31, 2025. The number of employees did not change compared to the previous year. That makes Relmada Therapeutics the 38,824th largest employer in the world and 5,668th in the United States.
Employees
17
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$3,642,670
Market Cap
341.34M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 17 | 0 | - |
| Dec 31, 2024 | 17 | -3 | -15.00% |
| Dec 31, 2023 | 20 | 6 | 42.86% |
| Dec 31, 2022 | 14 | 4 | 40.00% |
| Dec 31, 2021 | 10 | -4 | -28.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Employee RankingsRLMD News
- 6 weeks ago - Relmada Therapeutics to Participate at the Wells Fargo 21st Annual Healthcare Conference - GlobeNewsWire
- 2 months ago - Relmada Therapeutics reports Q2 EPS (11c), consensus (20c) - TheFly
- 2 months ago - Relmada Therapeutics Earnings Call Transcript: Q2 2026 - Transcripts
- 2 months ago - Relmada Therapeutics Quarterly report: Q2 2026 - Filings
- 2 months ago - Relmada Therapeutics Earnings release: Q2 2026 - Filings
- 2 months ago - Relmada Therapeutics appoints Bipin Dalmia as chief business officer - TheFly
- 2 months ago - Relmada Therapeutics names Bipin Dalmia chief business officer - TheFly
- 2 months ago - Relmada Therapeutics Appoints Uro-Oncology Leader Bipin Dalmia as Chief Business Officer - GlobeNewsWire